Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation product
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat dietClinical Science, 2010
- LC–MS–MS Development and Validation for Simultaneous Quantitation of Metformin, Glimepiride and Pioglitazone in Human Plasma and Its Application to a Bioequivalence StudyChromatographia, 2009
- Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2008
- HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studiesJournal of Pharmaceutical and Biomedical Analysis, 2008
- Sensitive liquid chromatography tandem mass spectrometry method for the quantification of sitagliptin, a DPP‐4 inhibitor, in human plasma using liquid–liquid extractionBiomedical Chromatography, 2007
- Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?Nature Clinical Practice Endocrinology & Metabolism, 2007
- Review of sitagliptin phosphate: a novel treatment for type 2 diabetesVascular Health and Risk Management, 2007
- Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese SubjectsThe Journal of Clinical Pharmacology, 2006
- First Generation Process for the Preparation of the DPP-IV Inhibitor SitagliptinOrganic Process Research & Development, 2005
- Spectrofluorimetric analysis of certain 4-quinolone in pharmaceuticals and biological fluidsPharmaceutica Acta Helvetiae, 2000